Substrate reduction therapy
The glycosphingolipidoses are a family of storage diseases that arise due to incomplete catabolism of glycosphingolipids (GSLs) in the lysosome (Wraith, 2002). The majority are autosomal recessive disorders and result from mutations in the genes that encode the catabolic enzymes of the lysosome (Win...
Những tác giả chính: | Platt, F, Butters, T |
---|---|
Định dạng: | Book section |
Được phát hành: |
Springer US
2007
|
Những quyển sách tương tự
-
Substrate reduction therapy in mouse models of the glycosphingolipidoses.
Bằng: Platt, F, et al.
Được phát hành: (2003) -
Substrate reduction therapy.
Bằng: Platt, F, et al.
Được phát hành: (2008) -
Substrate reduction therapy for glycosphingolipid storage disorders.
Bằng: Lachmann, R, et al.
Được phát hành: (2001) -
Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
Bằng: Andersson, U, et al.
Được phát hành: (2004) -
Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
Bằng: Platt, F, et al.
Được phát hành: (2000)